Dana-Farber Cancer Institute


Dana-Farber Joins Parker Institute for Cancer Immunotherapy to Accelerate Cures for the World’s Gravest Cancers

October 14, 2022

Dana-Farber Cancer Institute, one of the world’s leading cancer research and treatment centers, has partnered with the Parker Institute for Cancer Immunotherapy, the leading network of immuno-oncology expertise in the world, as a member of the PICI Network with a goal to better understand the tumor microenvironment across cancer types and translate these basic discoveries to the clinic as impactful cancer immunotherapies.